Clinical trial
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients…
NCT00460174 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00460174 |
|---|---|
| Title | Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer |
| Official title | A Phase II Trial of Weekly Gemcitabine Hydrochloride and Bevacizumab in Combination With Abdominal Radiation Therapy in Patients With Localized Pancreatic Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | bevacizumab, gemcitabine, conventional surgery, radiation therapy |
| Enrollment | 31 |
| Start date | Oct 10, 2005 |
| Primary completion | Dec 17, 2007 |
| Completion | Jul 16, 2010 |
| First posted | Apr 13, 2007 |
| Last update posted | Oct 29, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: